Company Description
Mannatech, Incorporated operates as a wellness solution provider.
The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products.
It primarily sells its products through network marketing distribution channels and e-commerce model.
The company operates in the United States, Canada, Mexico, Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, the United Kingdom, Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, Thailand and China, as well as Belgium, France, Greece, Italy, Luxembourg, and Poland.
Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.
| Country | United States |
| Founded | 1993 |
| IPO Date | Feb 16, 1999 |
| Industry | Food Distribution |
| Sector | Consumer Staples |
| Employees | 170 |
| CEO | Landen Fredrick |
Contact Details
Address: 1410 Lakeside Parkway, Suite 200 Flower Mound, Texas 75028 United States | |
| Phone | 972 471 7400 |
| Website | mannatech.com |
Stock Details
| Ticker Symbol | MTEX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001056358 |
| CUSIP Number | 563771203 |
| ISIN Number | US5637712036 |
| Employer ID | 75-2508900 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Landen Granvel Fredrick | President and Chief Executive Officer |
| James Clavijo CPA | Executive Officer |
| Erin Kemmler Barta J.D. | General Counsel and Corporate Secretary |
| Dr. Steve Nugent | Chief Science and Health Officer and Chairman of Scientific Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 24, 2026 | 8-K | Current Report |
| Apr 24, 2026 | SCHEDULE 13D | Filing |
| Apr 21, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 21, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 15, 2026 | 8-K | Current Report |
| Apr 15, 2026 | 10-K | Annual Report |
| Apr 2, 2026 | NT 10-K/A | [Amend] Notification of inability to timely file Form 10-K |
| Apr 2, 2026 | 8-K | Current Report |
| Apr 1, 2026 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Mar 24, 2026 | 8-K | Current Report |